Conclusions
Acid-labile formylation of N-terminal proline of HIV-1 p24gag was found by proteomics. The role of formylation of human immunodeficiency virus type 1 p24gag is unclear so far, but it is surmised that the acid-labile formylation of HIV-1LAV-1 p24gag may play a critical role in the formation of the HIV-1 core for conferring HIV-1 infectivity. Furthermore, peptide-mass fingerprinting data suggest that two isoforms of cyclophilin A (CyPA), one with an isoelectric point (pI) of 6.40 and one with a pI of 6.53, are inside the viral membrane and another isoform with a pI of 6.88 is outside the viral membrane, and that the CyPA isoform with a pI of 6.53 is N-acetylated. The mechanisms that permit the redistribution of CyPA on the viral surface have not yet been clarified, but it is surmised that the CyPA isoform with a pI of 6.88 may play a critical role in the attachment of virions to the surface of target cells, and both the CyPA isoforms with pIs of 6.40 and 6.53 may regulate the conformation of the HIV-1 capsid protein.
Proteome analysis of HIV-1LAV-1 is very useful in understanding biological phenomena at the molecular level by identifying new proteins and co/post-translational modifications that are indispensable to viral replication, and in finding out attractive targets for the future AIDS-therapies.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Brennan, R. O., and Durack, D. T., 1981, Gay compromise syndrome. Lancet 2:1338–1339.
Barre-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vezinet-Brun, F., Rouzioux, C., Rozenbaum, W. and Montagnier, L., 1983, Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868–871.
Bess, J. W., Gorelick, R. J., Bosche W. J., Henderson, L. E. and Arthur, L. O., 1997., Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations. Virology 230:134–144.
Biemann, K., 1990, Appendix 5. Nomenclature for peptide fragment ions (positive ions). Methods Enzymol. 193:886–887.
Bryant, M., and Ratner, L., 1990, Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. USA 87:523–527.
Bukrinskaya, A. G., Ghorpade, A., Heinzinger, N. K., Smithgall, T. E., Lewis, R. E. and Stevenson, M., 1996, Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA. Proc. Natl. Acad. Sci. USA 93:367–371.
CDC 1982. Epidemiologic aspects of the current outbreak of Kaposi’s sarcoma and opportunistic infections. N. Engl. J. Med. 306: 248–252
D’Souza, M. P. and Harden, V. A., 1996, Chemokines and HIV-1 second receptors. Nature Med. 2:1293–1300.
Davis, K. C., Horsburgh C. R., Hasiba U., Schocket A. L., and Kirkpatrick C. H., 1983, Acquired immunodeficiency syndrome in a patient with hemophilia. Ann. Intern. Med. 98:284–286.
Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Smith, M. W., Allikmets, R., Goedert, J. J., Buchbinder, S. P., Vittinghoff, E., Gomperts, E., Donfield, S., Vlahov, D., Kaslow, R., Saah, A., Rinaldo, C., Detels, R. and O’Brien, S. J., 1996, Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study (see comments) (published erratum appears in Science 1996 Nov 15;274(5290):1069). Science 273:1856–1862.
Endrich, M. M., Gehrig, P. and Gehring, H., 1999, Maturation-induced conformational changes of HIV-1 capsid protein and identification of two high affinity sites for cyclophilins in the C-terminal domain, J. Biol. Chem. 26:5326–5332.
Franke, E. K., Yuan, H. E. and Luban, J., 1994, Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372:359–362.
Gallay, P., Swingler, S., Aiken, C. and Trono, D., 1995, HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell 80:379–388.
Gallo, R., Wong-Staal, F., Montagnier, L., Haseltine, W. A. and Yoshida, M., 1988, HIV/HTLV gene nomenclature. Nature 333:504.
Gamble, T. R., Vajdos, F. F., Yoo, S., Worthylake, D. K., Houseweart, M., Sundquist, W. I. and Hill, C. P., 1996, Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 87:1285–1294.
Gharahdaghi, F., Weinberg, C. R., Meagher, D. A., Imai, B. S. and Mische, S. M., 1999, Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity. Electrophoresis 20:601–605.
Gitti, R. K., Lee, B. M., Walker, J., Summers, M. F., Yoo, S. and Sundquist, W. I., 1996., Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science 273:231–235.
Gluschankof, P., Mondor, I., Gelderblom, H. R. and Sattentau, Q. J., 1997, Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations. Virology 230:125–133.
Görg, A., Obermaier, C., Boguth, G., Csordas, A., Diaz, J. J. and Madjar, J. J., 1997, Very alkaline immobilized pH gradients for two-dimensional electrophoresis of ribosomal and nuclear proteins. Electrophoresis 18: 328–337.
Gottlieb, M. S., Schroff, R., Schanker H. M., Weisman, J. D., Fan, P., Wolf R.T. and Saxon, A., 1981, Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N. Engl. J. Med. 305:1425–1431.
Gulick, R.M., Mellors, J. W., Havlir, D., Eron, J. J., Gonzalez, C., McMahon, D., Richman, D. D., Valentine, F. T., Jonas, L., Meibohm, A., Emini, E. A. and Chodakewitz, J. A., 1997, Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N. Engl. J. Med. 337:734–739.
Haendler, B., Hofer-Warbinek, R., Hofer, E., 1987, Complementary DNA for human T-cell cyclophilin. EMBO J. 6:947–950.
Hammer, S. M., Squires, K. E., Hughes, M. D., Grimes, J. M., Demeter, L. M., Currier, J. S., Eron, J. J., Feinberg, J. E., Balfour, H. H., Deyton, L. R., Chodakewitz, J. A. and Fischl, M. A, 1997, A controlled trial of two nucleoside analogues plus idinavir in person and CD4 cell counts of 200 or less. N. Engl. J. Med. 337:725–733.
Jin, Z. G., Melaragno, M. G., Liao, D. F., Yan, C., Haendeler, J., Suh, Y. A., Lambeth, J. D. and Berk, B. C., 2000, Cyclophilin A is a secreted growth factor induced by oxidative stress. Circ. Res. 87:789–796.
Kieffer, L. J., Thalhammer, T. and Handschumacher, R. E., 1992, Isolation and characterization of a 40-kDa cyclophilin-related protein. J. Biol. Chem. 267:5503–5507.
Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J. and Hendrickson, W. A., 1998, Structure of an HIV gp 120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393:648–659.
Laemmli, U. K., 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685.
Levy, J. A., Hoffman, A. D., Kramer, S. M., Landis, J. A., Shimabukuro, J. M. and Oshiro, L. S., 1984, Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science 225:840–842.
Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A. and Landau, N. R., 1996, Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367–377.
Maddon, P., Dalgleish, A., McDougal, J., Clapham, P., Weiss, R. and Axel, R., 1986, The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333–348.
Masur, H., Michelis, M. A., Greene, J. B., Onorato, I., Stouwe, R. A., Holzman, R. S., Wormser, G., Brettman, L., Lange, M., Murray, H. W., and Cunningham-Rundles, S., 1981, An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N. Engl. J. Med. 305:1431–1438.
McGrath, M., Witte, O., Pincus, T. and Weissman, I. L., 1978, Retrovirus purification: method that conserves envelope glycoprotein and maximizes infectivity J. Virol. 25:923–927.
Michael, N. L., Chang, G., Louie, L. G., Mascola, J. R., Dondero, D., Birx, D. L. and Sheppard, H. W., 1997, The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nature Med. 3:338–340.
Misumi, S., Nakajima, R., Takamune, N. and Shoji, S., 2001b, A cyclic dodecapeptide-multiple-antigen-peptide-conjugate from undecapeptidyl arch (from Arg168 to Cys178) of extracellular loop2 in CCR5 as a novel HIV-1 vaccine. J. Virol. 75:11614–11620.
Misumi, S., Takamune, N., Ido, Y., Hayashi, S., Endo, M., Mukai, R., Tachibana, K., Umeda, M. and Shoji, S., 2001a, Evidence as a HIV-1 self-defense vaccine of cyclic chimeric dodecapeptide warped from undecapeptidyl arch of exracellular loop 2 in both CCR5 and CXCR4. Biochem. Biophys. Res. Commun. 285:1309–1316.
Ott, D. E., 1997, Cellular proteins in HIV virions. Rev. Med. Virol. 7:167–180.
Ott, D. E., Coren, L. V., Johnson, D. G., Kane, B. P., Sowder, R. C., Kim, Y. D., Fisher, R. J., Zhou, X. Z., Lu, K. P. and Henderson, L. E., 2000, Actin-binding cellular proteins inside human immunodeficiency virus type 1. Virology 266:42–51.
Ott, D. E., Coren, L. V., Johnson, D. G., Sowder II, R. C., Arthur, L. O. and Henderson, L. E., 1995, Analysis and localization of cyclophilin A found in the virions of human immunodeficiency virus type 1 MN strain. AIDS Res. Hum. Retroviruses 11:1003–1006.
Popovic, M., Sarngadharan, M. G., Read, E. and Gallo, R. C., 1984, Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497–500.
Ryffel, B., Woerly, G., Greiner, B., Haendler, B., Mihatsch, M. J. and Foxwell, B. M., 1991, Distribution of the cyclosporine binding protein cyclophilin in human tissues. Immunology 72:399–404.
Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C. M., Saragosti, S., Lapoumeroulie, C., Cognaux, J., Forceille, C., Muyldermans, G., Verhofstede, C., Burtonboy, G., Georges, M., Imai, T., Rana, S., Yi, Y., Smyth, R. J., Collman, R. G., Doms, R. W., Vassart, G. and Parmentier, M., 1996, Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722–725.
Saphire, A. C., Bobardt, M. D. and Gallay, P. A., 1999, Host cyclophilin A mediates HIV-1 attachment to target cells via heparans. EMBO J. 18:6771–6785.
Scarlatti, G., Tresoldi, E., Bjorndal, A., Fredriksson, R., Colognesi, C., Deng, H. K., Malnati, M. S., Plebani, A., Siccardi, A. G., Littman, D. R., Fenyo, E. M. and Lusso, P., 1997, In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression, Nature Med. 3:1259–1265.
Sherry, B., Zybarth, G., Alfano, M., Dubrovsky, L., Mitchell, R., Rich, D., Ulrich, P., Bucala, R., Cerami, A. and Bukrinsky, M., 1998, Role of cyclophilin A in the uptake of HIV-1 by macrophages and T lymphocytes. Proc. Natl. Acad. Sci. USA 95:1758–1763.
Shevchenko, A., Wilm, M., Vorm, O. and Mann, M., 1996, Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68:850–858.
Shiraishi, T., Misumi, S., Takama, M., Takahashi, I. and Shoji, S., 2001, Myristoylation of human immunodeficiency virus type 1 gag protein is required for efficient env protein transportation to the surface of cells. Biochem. Biophys. Res. Commun. 282:1201–1205.
Tashiro, A., Shoji, S. and Kubota, Y., 1989, Antimyristoylation of the gag proteins in the human immunodeficiency virus-infected cells with N-myristoyl glycinal diethylacetal resulted in inhibition of virus production. Biochem. Biophys. Res. Commun. 165:1145–1154.
Thali, M., Bukovsky, A., Kondo, E., Rosenwirth, B., Walsh, C. T., Sodroski J. and Göttlinger, H. G., 1994, Functional association of cyclophilin A with HIV-1 virions. Nature 372:363–365
Tsunasawa, S. and Narita, K., 1976, Acylamino acid-releasing enzyme from rat liver. Methods in Enzymology, XLV, 552–561.
von Schwedler, U. K., Stemmler, T. L., Klishko, V. Y., Li, S., Albertine, K. H., Davis, D. R. and Sundquist, W. I., 1998, Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J. 17:1555–1568.
Wilkins, M.R., Gasteiger, E., Gooley, A. A., Herbert, B. R., Molloy, M. P., Binz, P. A., Ou, K., Sanchez, J. C., Bairoch, A., Williams, K. L. and Hochstrasser, D. F., 1999, High-throughput mass spectrometric discovery of protein post-translational modifications. J. Mol. Biol. 289:645–657.
Wilm, M., Shevchenko, A., Houthaeve, T., Breit, S., Schweigerer, L., Fotsis, T. and Mann, M., 1996., Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature 379:466–469.
Wyatt, R., Kwong, P. D., Desjardins, E., Sweet, R. W., Robinson, J., Hendrickson, W. A. and Sodroski, J. G., 1998, The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393:705–711.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Kluwer Academic Publishers
About this chapter
Cite this chapter
Misumi, S., Takamune, N., Shoji, S. (2004). Proteomics of HIV-1 Virion. In: Hondermarck, H. (eds) Proteomics: Biomedical and Pharmaceutical Applications. Springer, Dordrecht. https://doi.org/10.1007/1-4020-2323-5_14
Download citation
DOI: https://doi.org/10.1007/1-4020-2323-5_14
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-2322-4
Online ISBN: 978-1-4020-2323-1
eBook Packages: Springer Book Archive